epigallocatechin gallate has been researched along with Degenerative Diseases, Central Nervous System in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (21.74) | 29.6817 |
| 2010's | 13 (56.52) | 24.3611 |
| 2020's | 5 (21.74) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; Dong, L; Tan, Y; Wang, D; Wang, F; Wang, H; Zhu, W | 1 |
| Bourgeois, B; Habacher, H; Khanna, Y; Lenard, AJ; Madl, T; Madreiter-Sokolowski, C; Zhou, Q | 1 |
| Alarcón-Jimenez, J; Cuerda-Ballester, M; de Bernardo, N; de la Rubia Ortí, JE; Lajara Romance, JM; Proaño, B; Villaron-Casales, C | 1 |
| Sharma, A; Thakur, A; Tuli, HS | 1 |
| Fukutomi, R; Isemura, M; Koyama, Y; Nakamura, Y; Ohishi, T; Pervin, M | 1 |
| Cordeiro, Y; Gonçalves, PB; Sodero, ACR | 1 |
| Airoldi, C; Bonanomi, M; De Gioia, L; Gatta, E; Natalello, A; Pellistri, F; Penco, A; Regonesi, ME; Relini, A; Tortora, P; Vertemara, J; Visentin, C | 1 |
| Jimenez-Del-Rio, M; Martinez-Perez, DA; Velez-Pardo, C | 1 |
| Khademi, E; Khalatbary, AR | 1 |
| Elbaz, HA; Hüttemann, M; Lee, I; Malek, MH; Shay, J; Zielske, SP | 1 |
| Goto, S; Isemura, M; Monira, P; Nakamura, Y; Ohishi, T | 1 |
| Amit, T; Kalfon, L; Mandel, SA; Reznichenko, L; Weinreb, O; Youdim, MB | 1 |
| Kumar, A; Kumar, P | 1 |
| Emmer, KL; Giasson, BI; Waxman, EA | 1 |
| Chopra, K; Kuhad, A; Tiwari, V | 1 |
| Cavalieri, E; Darra, E; Ebner, FH; Mariotto, S; Suzuki, H | 1 |
| Abraham, NG; Calogero, C; Caruso, C; Fabio, G; Nader, AG; Scapagnini, G; Sonya, V; Vasto, S; Zella, D | 1 |
| Calabrese, V; Caruso, C; Scapagnini, G | 1 |
| Gomez-Pinilla, F; Nguyen, TT | 1 |
| Maag, JL; Musgrave, IF; Smid, SD | 1 |
| Amit, T; Mandel, S; Weinreb, O; Youdim, MB | 1 |
| Amit, T; Mandel, S; Reznichenko, L; Weinreb, O; Youdim, MB | 1 |
| Amit, T; Avramovich-Tirosh, Y; Mandel, S; Youdim, MB | 1 |
13 review(s) available for epigallocatechin gallate and Degenerative Diseases, Central Nervous System
| Article | Year |
|---|---|
Beneficial Effects of Epigallocatechin-3-
Topics: Animals; Antineoplastic Agents; Antioxidants; Catechin; Chlorogenic Acid; Curcumin; Humans; Neurodegenerative Diseases; Neuroprotective Agents; Resveratrol | 2021 |
Green Tea Epigallocatechin-3-gallate (EGCG) Targeting Protein Misfolding in Drug Discovery for Neurodegenerative Diseases.
Topics: alpha-Synuclein; Alzheimer Disease; Amyloid beta-Protein Precursor; Catechin; Drug Discovery; Humans; Molecular Targeted Therapy; Neurodegenerative Diseases; Parkinson Disease; Protein Aggregates; Protein Folding; Tea | 2021 |
The green tea polyphenolic catechin epigallocatechin gallate and neuroprotection.
Topics: Animals; Apoptosis; Brain; Brain Injuries; Catechin; Clinical Trials as Topic; Humans; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Plant Extracts; Spinal Cord Injuries; Tea | 2020 |
Molecular Mechanisms and Therapeutic Effects of (-)-Epicatechin and Other Polyphenols in Cancer, Inflammation, Diabetes, and Neurodegeneration.
Topics: Catechin; Humans; Inflammation; Mitochondria; Neoplasms; Neurodegenerative Diseases; Polyphenols; Reactive Oxygen Species; Signal Transduction | 2015 |
Anti-inflammatory Action of Green Tea.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Camellia sinensis; Cardiovascular Diseases; Catechin; Diabetes Mellitus; Humans; Inflammation Mediators; Neoplasms; Neurodegenerative Diseases; Obesity; Reactive Oxygen Species; Tea | 2016 |
Cell signaling pathways and iron chelation in the neurorestorative activity of green tea polyphenols: special reference to epigallocatechin gallate (EGCG).
Topics: Alzheimer Disease; Catechin; Flavonoids; Humans; Iron Chelating Agents; Neurodegenerative Diseases; Nootropic Agents; Phenols; Polyphenols; Signal Transduction; Tea | 2008 |
Use of STAT1 inhibitors in the treatment of brain I/R injury and neurodegenerative diseases.
Topics: Animals; Brain; Bridged Bicyclo Compounds; Catechin; Humans; Janus Kinases; Molecular Structure; Neurodegenerative Diseases; Neuroprotective Agents; Phloroglucinol; Reperfusion Injury; Signal Transduction; STAT1 Transcription Factor; Terpenes | 2011 |
Modulation of Nrf2/ARE pathway by food polyphenols: a nutritional neuroprotective strategy for cognitive and neurodegenerative disorders.
Topics: Animals; Antioxidants; Catechin; Cognition Disorders; Curcumin; Diet; Food; Heme Oxygenase-1; Humans; Molecular Structure; Neurodegenerative Diseases; Neuroprotective Agents; NF-E2-Related Factor 2; Polyphenols; Response Elements | 2011 |
Natural mood foods: the actions of polyphenols against psychiatric and cognitive disorders.
Topics: Affect; Animals; Antioxidants; Brain; Catechin; Cognition Disorders; Curcumin; Diet; Energy Intake; Energy Metabolism; Food Preferences; Humans; Nervous System Physiological Phenomena; Neurodegenerative Diseases; Oxidative Stress; Polyphenols | 2012 |
Dietary polyphenol-derived protection against neurotoxic β-amyloid protein: from molecular to clinical.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Catechin; Cell Line; Curcumin; Diet; Humans; Models, Molecular; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Plants; Polyphenols; Resveratrol; Stilbenes; Tea | 2012 |
Cell signaling pathways in the neuroprotective actions of the green tea polyphenol (-)-epigallocatechin-3-gallate: implications for neurodegenerative diseases.
Topics: Animals; Catechin; Flavonoids; Humans; Neurodegenerative Diseases; Neuroprotective Agents; Phenols; Polyphenols; Signal Transduction; Tea | 2004 |
Green tea catechins as brain-permeable, natural iron chelators-antioxidants for the treatment of neurodegenerative disorders.
Topics: Animals; Blood-Brain Barrier; Brain; Catechin; Cell Death; Gene Expression; Humans; Hypoxia; Iron; Iron Chelating Agents; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Tea | 2006 |
Targeting multiple Alzheimer's disease etiologies with multimodal neuroprotective and neurorestorative iron chelators.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Brain; Catechin; Cell Cycle; Humans; Hydroxyquinolines; Iron; Iron Chelating Agents; Neurodegenerative Diseases; Neuroprotective Agents; PC12 Cells; Piperazines; Rats | 2008 |
1 trial(s) available for epigallocatechin gallate and Degenerative Diseases, Central Nervous System
| Article | Year |
|---|---|
Improvements in gait and balance in patients with multiple sclerosis after treatment with coconut oil and epigallocatechin gallate. A pilot study.
Topics: Coconut Oil; Gait; Humans; Multiple Sclerosis; Neurodegenerative Diseases; Pilot Projects | 2023 |
9 other study(ies) available for epigallocatechin gallate and Degenerative Diseases, Central Nervous System
| Article | Year |
|---|---|
Discovery of potent small molecule inhibitors of DYRK1A by structure-based virtual screening and bioassay.
Topics: Adenosine Triphosphate; Animals; Biochemistry; Biological Assay; Chemistry, Pharmaceutical; Dose-Response Relationship, Drug; Down Syndrome; Drug Design; Dyrk Kinases; Humans; In Vitro Techniques; Inhibitory Concentration 50; Mice; Mice, Transgenic; Models, Chemical; Neurodegenerative Diseases; Phosphorylation; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases | 2012 |
EGCG Promotes FUS Condensate Formation in a Methylation-Dependent Manner.
Topics: Arginine; Catechin; Glycine; Humans; Methylation; Neurodegenerative Diseases; Proteins; RNA-Binding Protein FUS | 2022 |
Natural Moieties as Anti-Inflammatory Agents-Recent Patents.
Topics: Animals; Anti-Inflammatory Agents; Apigenin; Biological Products; Cardiovascular Diseases; Catechin; Coumaric Acids; Humans; Inflammation; Neoplasms; Neurodegenerative Diseases; Patents as Topic; Plants; Polyphenols; Quercetin | 2019 |
Epigallocatechin-3-gallate and related phenol compounds redirect the amyloidogenic aggregation pathway of ataxin-3 towards non-toxic aggregates and prevent toxicity in neural cells and Caenorhabditis elegans animal model.
Topics: Amyloid; Amyloidogenic Proteins; Animals; Ataxin-3; Caenorhabditis elegans; Catechin; Disease Models, Animal; Humans; Hydrogen Bonding; Molecular Docking Simulation; Nerve Tissue Proteins; Neurodegenerative Diseases; Neurons; Nuclear Proteins; Peptides; Phenols | 2017 |
Epigallocatechin-3-Gallate Protects and Prevents Paraquat-Induced Oxidative Stress and Neurodegeneration in Knockdown dj-1-β Drosophila melanogaster.
Topics: Animals; Animals, Genetically Modified; Antioxidants; Catechin; Disease Models, Animal; Dose-Response Relationship, Drug; Drosophila melanogaster; Drosophila Proteins; Female; Herbicides; Lipid Peroxidation; Locomotion; Male; Minocycline; Nerve Tissue Proteins; Neurodegenerative Diseases; Neuroprotective Agents; Oxidative Stress; Paraquat; Protein Deglycase DJ-1; Tyrosine 3-Monooxygenase | 2018 |
Protective effects of epigallocatechin gallate following 3-nitropropionic acid-induced brain damage: possible nitric oxide mechanisms.
Topics: Animals; Antioxidants; Behavior, Animal; Catechin; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Mitochondria; Motor Activity; Neurodegenerative Diseases; Neuroprotective Agents; Neurotoxicity Syndromes; Neurotoxins; Nitric Oxide; Nitro Compounds; Oxidative Stress; Propionates; Rats; Rats, Wistar | 2009 |
Residue Glu83 plays a major role in negatively regulating alpha-synuclein amyloid formation.
Topics: alpha-Synuclein; Amyloid; Catechin; Dopamine; Flavanones; Glutamic Acid; Humans; Mutation; Neurodegenerative Diseases; Neuroprotective Agents | 2010 |
Epigallocatechin-3-gallate ameliorates alcohol-induced cognitive dysfunctions and apoptotic neurodegeneration in the developing rat brain.
Topics: Animals; Animals, Newborn; Apoptosis; Brain; Catechin; Cognition Disorders; Ethanol; Male; Maze Learning; Neurodegenerative Diseases; Random Allocation; Rats; Rats, Wistar | 2010 |
Therapeutic potential of dietary polyphenols against brain ageing and neurodegenerative disorders.
Topics: Aging; Antioxidants; Brain; Caffeic Acids; Catechin; Curcumin; Diet; Flavonoids; Neurodegenerative Diseases; Neuroprotective Agents; Phenols; Phenylethyl Alcohol; Polyphenols | 2010 |